Legacy Advisors, LLC Abbott Laboratories Transaction History

Legacy Advisors, LLC

$918 Million
Q3 2024

A detailed history of Legacy Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Legacy Advisors, LLC holds 32,670 shares of ABT stock, worth $3.79 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

32,670

Previous 31,152 4.87%

Holding current value

$3.79 Million

Previous $3.24 Million 15.04%

% of portfolio

0.41%

Previous 0.39%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $151,906 - $179,321	1,518 Added 4.87%	32,670 $3.72 Million
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $102,946 - $114,913	1,022 Added 3.39%	31,152 $3.24 Million
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $584,289 - $645,321	-5,335 Reduced 15.04%	30,130 $3.42 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $921,110 - $1.13 Million	10,213 Added 40.44%	35,465 $3.9 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $35,250 - $42,294	-369 Reduced 1.44%	25,252 $2.45 Million
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $1.89 Million - $2.11 Million	18,752 Added 272.99%	25,621 $2.79 Million
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $39,131 - $46,060	-404 Reduced 5.55%	6,869 $695,000
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $154,282 - $180,996	1,623 Added 28.73%	7,273 $798,000
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $63,184 - $73,155	653 Added 13.07%	5,650 $547,000
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $18,270 - $22,083	-179 Reduced 3.46%	4,997 $543,000
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $385,159 - $469,677	3,378 Added 187.88%	5,176 $613,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $6,585 - $8,063	57 Added 3.27%	1,798 $253,000
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $1,399 - $1,548	12 Added 0.69%	1,741 $206,000
Q1 2021 Apr 12, 2021	BUY	$108.84 - $128.23 $188,184 - $221,709	1,729 New	1,729 $207,000
Q3 2019 Oct 10, 2019	SELL	$81.84 - $88.74 $225,551 - $244,567	-2,756 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $14,576 - $17,000	-200 Reduced 6.77%	2,756 $232,000
Q1 2019 Apr 08, 2019	SELL	$66.22 - $80.06 $150,716 - $182,216	-2,276 Reduced 43.5%	2,956 $236,000
Q4 2018 Jan 14, 2019	SELL	$65.56 - $74.27 $1.29 Million - $1.47 Million	-19,729 Reduced 79.04%	5,232 $378,000
Q3 2018 Oct 18, 2018	BUY	$60.81 - $73.36 $1.46 Million - $1.76 Million	24,041 Added 2613.15%	24,961 $1.83 Million
Q2 2018 Jul 19, 2018	BUY	$57.57 - $63.54 $32,008 - $35,328	556 Added 152.75%	920 $56,000
Q1 2018 Apr 17, 2018	SELL	$56.27 - $63.62 $43,946 - $49,687	-781 Reduced 68.21%	364 $21,000
Q4 2017 Jan 26, 2018	BUY	$53.68 - $57.47 $45,091 - $48,274	840 Added 275.41%	1,145 $65,000
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $14,658 - $16,360	305 New	305 $16,000
Q1 2017 Nov 02, 2017	SELL	N/A	-620 Closed	0 $0
Q4 2016 Nov 03, 2017	BUY	N/A	620	620 $23,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.

Account

Legacy Advisors, LLC Abbott Laboratories Transaction History